Tuesday, September 1, 2026 SourcesAbout🌓
🇨🇦 CA ▾
Américas🇧🇷 Brasil🇺🇸 United States🇨🇦 Canada🇻🇪 Venezuela🇲🇽 México🇦🇷 Argentina
Europa🇫🇷 France🇬🇧 United Kingdom🇪🇸 España🇵🇹 Portugal🇩🇪 Deutschland🇷🇺 Россия
Ásia-Pacífico🇯🇵 日本🇦🇺 Australia🇮🇳 India🇰🇷 대한민국🇨🇳 中国
África🇿🇦 South Africa
BREAKING
› Calgary man charged with running $164M Ponzi scheme involving more than 1,000 victims› Canadians Conners, Taylor added to International team for Presidents Cup› Quantum BioPharma Announces Plans to Voluntarily Delist its Class B Shares from the Canadian Securities Exchange› Reference to Indigenous peoples removed from Premier Smith's Alberta Day statement 'in error'› Winnipeg Jets sign Altona’s Cole Kehler to be full-time EBUG› Danielle Smith says Tennessee trip isn’t sending wrong message during trade war› Hannah Einbinder, Emma Seligman and others sign letter challenging antisemitism claims against Mark Ruffalo› OPP open homicide investigation into death of woman in Spencerville› How Sean Keys’ power could fit into the Blue Jays’ lineup› EDITORIAL: Feds say their climate law is unenforceable› Calgary man charged with running $164M Ponzi scheme involving more than 1,000 victims› Canadians Conners, Taylor added to International team for Presidents Cup› Quantum BioPharma Announces Plans to Voluntarily Delist its Class B Shares from the Canadian Securities Exchange› Reference to Indigenous peoples removed from Premier Smith's Alberta Day statement 'in error'› Winnipeg Jets sign Altona’s Cole Kehler to be full-time EBUG› Danielle Smith says Tennessee trip isn’t sending wrong message during trade war› Hannah Einbinder, Emma Seligman and others sign letter challenging antisemitism claims against Mark Ruffalo› OPP open homicide investigation into death of woman in Spencerville› How Sean Keys’ power could fit into the Blue Jays’ lineup› EDITORIAL: Feds say their climate law is unenforceable
Business

Knight Therapeutics Announces Regulatory Approval of TAVALISSE® in Colombia

Financial Post ·

MONTREAL, Sept.

01, 2026 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (“Knight”) (TSX: GUD), a pan-American (ex-US) pharmaceutical company, announced today that it has received regulatory approval from INVIMA, the Colombi

Read the full article on Financial Post ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.

More from Financial Post

See all ›

Quantum BioPharma Announces Plans to Voluntarily Delist its Class B Shares from the Canadian Securities Exchange

Financial Post · 22 min ago

Care Can’t Wait! Long-Term Care workers hold province wide day of action calling out delays in contract negotiations with Extendicare

Financial Post · 53 min ago

InspireSemi Provides Corporate and Financing Updates

Financial Post · 1 h ago

Canadian Salsa Festivals Project Tour Expands with the Inaugural Salsa at Niagara Falls September 12-13 │ Noon – 10P with Nightly Fireworks

Financial Post · 1 h ago

More in Business

See all ›

Quantum BioPharma Announces Plans to Voluntarily Delist its Class B Shares from the Canadian Securities Exchange

Financial Post · 22 min ago

Care Can’t Wait! Long-Term Care workers hold province wide day of action calling out delays in contract negotiations with Extendicare

Financial Post · 53 min ago

InspireSemi Provides Corporate and Financing Updates

Financial Post · 1 h ago

Canadian Salsa Festivals Project Tour Expands with the Inaugural Salsa at Niagara Falls September 12-13 │ Noon – 10P with Nightly Fireworks

Financial Post · 1 h ago

News of the day: Bank of Canada expectations, renting-out pays off, income tax rates, immigration system reset, Barton joins Invest in Canada and more

Financial Post · 1 h ago

Hammond Power Solutions Increases Dividend to $0.29 Per Share

Financial Post · 2 h ago